Core Points - Amwell granted RSUs covering 16,737 shares of its Class A common stock to four new employees as an inducement for their employment [1][2] - The RSUs will vest 25% on the first anniversary of the grant date, with the remaining 75% vesting in equal increments every three months over three years [1] - The grants were approved by the Compensation Committee under Amwell's Inducement Plan and comply with NYSE's Listed Company Manual Rule 303A.08 [2] Company Overview - Amwell provides a comprehensive, technology-enabled care platform for payers and health systems, enhancing patient access to affordable and effective care [3] - The platform supports various clinical programs and offers integrated solutions for patients seeking care online, operating at a large scale to serve millions [3] - Amwell has been serving major healthcare organizations in the U.S. and globally for nearly two decades [3]

Company Overview - Amwell is a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, offering payers and health systems a unified care platform [2] - The platform enhances patient access to convenient, affordable, and effective care, integrating various clinical programs [2] - Amwell has been operational for almost two decades, serving major healthcare organizations in the U.S. and globally [2] Upcoming Events - Amwell will participate in the TD Cowen 24th Annual Health Care conference in Boston on March 4, 2025 [1] - Ido Schoenberg, M.D., the chairman and CEO of Amwell, will engage in a fireside chat at 9:10 a.m. ET, with an audio webcast available for investors [1]

American Well Corporation (NYSE:AMWL) Q4 2024 Earnings Conference Call February 12, 2025 5:00 PM ET Company Participants Sue Dooley - Head of Investor Relations Ido Schoenberg - Chairman & Chief Executive Officer Mark Hirschhorn - Chief Financial Officer Conference Call Participants Craig Hettenbach - Morgan Stanley Stan Berenshteyn - Wells Fargo Securities Jailendra Singh - Truist Securities Eric Percher - Nephron Research Charles Rhyee - TD Cowen Matt Shea - Needham & Company Kevin Caliendo - UBS David La ...

American Well Corporation (AMWL) reported $71.01 million in revenue for the quarter ended December 2024, representing a year-over-year increase of 0.5%. EPS of -$2.77 for the same period compares to -$3.40 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $66.57 million, representing a surprise of +6.67%. The company delivered an EPS surprise of +1.77%, with the consensus EPS estimate being -$2.82.While investors closely watch year-over-year changes in headline numbers -- revenue a ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-39515 American Well Corporation (Exact name of Registrant as specified in its charter) | Delaware | 20-5009396 | | --- | --- | | (Sta ...

Exhibit 99.1 AMWELL® ANNOUNCES RESULTS FOR FOURTH QUARTER AND FULL YEAR 2024 BOSTON, Feb. 12, 2025 –Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the fourth quarter and full year ended Dec. 31, 2024. "During 2024, we advanced our business in ways that put us much closer to unlocking the value of Amwell and advancing our mission to modernize healthcare with our unified platform," said Ido Schoenberg, MD, ch ...

Core Insights - Amwell announced its financial results for Q4 and the full year ended December 31, 2024, highlighting its position as a leading provider of a comprehensive SaaS-based healthcare platform [1] Company Overview - Amwell is recognized as a leading hybrid care delivery enablement platform in the U.S. and globally, connecting providers, payers, patients, and innovators to enhance access to affordable, high-quality care [3] - The company supports digital health needs across various care types, including urgent, acute, post-acute, chronic care management, and healthy living [3] - Amwell has nearly two decades of experience and powers the digital care of 50 health plans, covering over 80 million lives, and collaborates with many of the largest health systems in the nation [3]

Group 1 - Analysts project that American Well Corporation (AMWL) will report a quarterly loss of $2.82 per share, an increase of 17.1% year over year [1] - Revenues for the upcoming quarter are expected to be $66.57 million, reflecting a decline of 5.8% from the same quarter last year [1] - The consensus EPS estimate has remained unchanged over the past 30 days, indicating a reassessment by covering analysts [1] Group 2 - The average prediction for 'Revenue- Platform subscription' is $32.56 million, showing a year-over-year increase of 19.4% [4] - Analysts estimate 'Revenue- Other' will be $8.47 million, indicating a decline of 24.8% year over year [4] - The estimated 'Revenue- Visits' is projected at $25.70 million, reflecting a decrease of 20% from the previous year [4] Group 3 - Over the past month, American Well shares have increased by 33.2%, outperforming the Zacks S&P 500 composite, which rose by 4.2% [5] - Based on its Zacks Rank 3 (Hold), AMWL is expected to perform in line with the overall market in the near future [5]

Company Overview - Amwell is a leading hybrid care delivery enablement platform in the United States and globally, connecting providers, payers, patients, and innovators to enhance access to affordable, high-quality care [3] - The company offers a comprehensive platform that supports various digital health needs, including urgent, acute, post-acute care, chronic care management, and healthy living [3] - Amwell has nearly two decades of experience and powers the digital care of over 50 health plans, representing more than 100 million covered lives, along with many of the largest health systems in the nation [3] Upcoming Earnings Report - Amwell will report its fourth quarter 2024 operating results after stock market trading hours on February 12, 2025 [1] - Following the earnings alert, the management team will host a live conference call and webcast at 5 p.m. ET to review the operating results and provide a general business update [1][2] - The full earnings report and the live audio webcast can be accessed through the Investors section of the company's website, with a replay available for approximately 90 days [2]

Partnership Overview - Vida Health partners with Amwell to provide personalized, high-touch care, aiming to reduce member friction, improve health outcomes, and lower costs [1] - The collaboration integrates Vida's cardiometabolic care solutions, including GLP-1s and anti-obesity medications, into Amwell's platform [7][9] Program Details - The program, Amwell Cardiometabolic Care Powered by Vida, offers a suite of services including obesity, diabetes prevention, management, and behavioral health support [5] - Care is tailored based on social factors such as food security, financial barriers, cultural norms, and beliefs [5] - Vida's services are available alongside Amwell's existing virtual primary care, urgent care, and behavioral health programs [5] Industry Context - Over 40% of American adults struggle with obesity, which increases the risk of diabetes, heart disease, and cancer [1] - Obesity and diabetes collectively cost the U S healthcare system more than $500 billion annually [1] Company Profiles - Amwell is a leading hybrid care delivery platform, connecting providers, payers, patients, and innovators to deliver affordable, high-quality care [6] - Amwell powers digital care for over 50 health plans, representing more than 100 million covered lives [6] - Vida Health is a virtual obesity and metabolic care provider, offering personalized care with a holistic approach combining human care and AI-powered insights [8] - Vida operates on a value-based pricing model, focusing on measurable outcomes and serving members in all 50 states [8] Strategic Impact - The partnership allows Amwell's health plan clients to offer members a single entry point for clinical and behavioral health support related to obesity and related illnesses [9] - Vida's programs adapt to patient needs, providing a personalized, cost-effective approach to weight loss and chronic disease management [9] - Amwell's clinical programs portfolio features virtual and digital care products from partners, offering a unified and comprehensive care model [9]